Publications by authors named "Valentina Tadini"

Myelination requires extensive plasma membrane rearrangements, implying that molecules controlling membrane dynamics play prominent roles. The large GTPase dynamin 2 (DNM2) is a well-known regulator of membrane remodeling, membrane fission, and vesicular trafficking. Here, we genetically ablated in Schwann cells (SCs) and in oligodendrocytes of mice.

View Article and Find Full Text PDF

Background: Sarcopenia is defined as the age-related loss of skeletal muscle mass and function. While all humans lose muscle with age, 2-5% of elderly adults develop functional consequences (disabilities). The aim of this study was to investigate muscle myogenesis in healthy elderly adults, with or without sarcopenia, compared with middle-aged controls using both in vivo and in vitro approaches to explore potential biomarker or causative molecular pathways associated with sarcopenic versus non-sarcopenic skeletal muscle phenotypes during ageing.

View Article and Find Full Text PDF
Article Synopsis
  • Advanced cancer patients often suffer from significant weight loss and muscle mass reduction, known as cancer cachexia, which affects their health and survival rates.
  • The study finds that IL-6, a protein secreted by tumor cells, accelerates autophagy (cellular breakdown) in muscle cells, which is linked to weight loss in these patients.
  • Targeting IL-6 trans-signaling could be a potential therapeutic approach to combat cancer cachexia and improve patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer cachexia, characterized by muscle loss in cancer patients, poses a significant challenge due to its unclear causes and lack of early predictive biomarkers, making early intervention crucial.
  • Advanced proteomic techniques were employed to analyze muscle biopsies, identifying distinct molecular changes in cancer cachexia patients compared to healthy individuals and those with age-related muscle loss.
  • This research provides insights into the mechanisms behind cancer-induced muscle wasting and suggests a shift from weight loss as a primary indicator of cachexia to a more accurate protein-based signature.
View Article and Find Full Text PDF